Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct:55:100790.
doi: 10.1016/j.yfrne.2019.100790. Epub 2019 Sep 19.

Neuroendocrine pathways underlying risk and resilience to PTSD in women

Affiliations
Review

Neuroendocrine pathways underlying risk and resilience to PTSD in women

Meghna Ravi et al. Front Neuroendocrinol. 2019 Oct.

Abstract

Women are twice as likely than men to suffer from posttraumatic stress disorder (PTSD). While women have increased exposure to traumatic events of many types and have greater prevalence of comorbid psychiatric disorders compared to men, these differences do not account for the overall sex difference in the prevalence of PTSD. The current review summarizes significant findings that implicate the role of estradiol, progesterone, and allopregnanolone in female risk for PTSD symptoms and dysregulation of fear psychophysiology that is cardinal to PTSD. We also discuss how these steroid hormones influence the stress axis and neural substrates critical for the regulation of fear responses. Understanding the role of ovarian steroid hormones in risk and resilience for trauma-related adverse mental health outcomes across the lifespan in women has important translational, clinical, and intergenerational implications for mitigating the consequences of trauma exposure.

Keywords: Estrogen; Fear psychophysiology; Neuroimaging; PTSD; Progesterone; Women.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Illustration of fear conditioning paradigms and fear responses related to PTSD.
Classical fear conditioning paradigms typically consist of a (A) conditioning (acquisition) phase, an (B) extinction phase, and sometimes an (C) extinction recall phase. In the conditioning phase (acquisition), a neutral stimulus (conditioned stimulus; CS) is paired with an aversive unconditioned stimulus (US; such as a mild shock or aversive air blast). Some paradigms have multiple neutral stimuli, where only one (CS+; danger cue) is paired with the aversive US while the other (CS−; safety cue) is not. In the extinction phase, the CS+ is no longer presented with the aversive US, and participants should learn to dissociate the CS from danger. In some paradigms, recall of the extinction memory (dissociation of the CS+ from danger) is assessed at a later time (extinction retention phase). Fear potentiated startle is another paradigm used, in which the startle response is measured in response to a loud but harmless tone (startle probe) in the presence of the CS+ and CS−. Deficits in fear inhibition during fear conditioning are analogous to the increased fear and fear generalization symptoms seen in PTSD, while deficits in extinction and extinction recall point to the re-experiencing and hyperarousal symptoms characteristic of PTSD.
Figure 2.
Figure 2.. Relationship between cycle phase, ovarian hormones, and fear conditioning.
Existing studies in women indicate no relationship between menstrual cycle phase/ovarian hormone levels on acquisition or extinction processes. Low E2/P4 concentrations (as seen in the early follicular phase) are associated with impaired extinction recall and fear inhibition. High E2 concentrations (seen in the late follicular phase) and high E2/P4 concentrations (seen in the early to mid luteal phase) are associated with enhanced extinction recall and fear inhibition. The effects of declining E2/P4 concentrations during the late luteal phase on fear conditioning processes remain to be assessed.

Similar articles

Cited by

References

    1. Dedert EA, Calhoun PS, Watkins LL, Sherwood A, and Beckham JC, Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence. Ann Behav Med 39 (2010) 61–78. - PMC - PubMed
    1. Keane TM, Marx BP, and Sloan DM, Post-Traumatic Stress Disorder: Definition, Prevalence, and Risk Factors in: Shiromani PJ, Keane TM, and LeDoux JE, (Eds.), Post-Traumatic Stress Disorder: Basic Science and Clinical Practice, Humana Press, New York, 2009, pp. 1–19.
    1. Rothbaum B, Foa EB, Riggs DS, Murdock T, and Walsh W, A Prospective Examination of Posttraumatic Stress Disorder in Rape Victims. Journal of Traumatic Stress (1992) 455–475.
    1. Rytwinski NK, Scur MD, Feeny NC, and Youngstrom EA, The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. J Trauma Stress 26 (2013) 299–309. - PubMed
    1. Pietrzak RH, Goldstein RB, Southwick SM, and Grant BF, Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Anxiety Disord 25 (2011) 456–65. - PMC - PubMed

Publication types